Skip to main content
Clinical Trials/ISRCTN64287972
ISRCTN64287972
Completed
未知

Functional outcome of the P.F.C. Sigma® RP-F knee system and the P.F.C. Sigma® knee system: a prospective, randomised controlled trial

South Tees Hospitals NHS Trust (UK)0 sites120 target enrollmentSeptember 12, 2007

Overview

Phase
未知
Intervention
Not specified
Conditions
Osteoarthritis of the knee
Sponsor
South Tees Hospitals NHS Trust (UK)
Enrollment
120
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2010 Results article in https://pubmed.ncbi.nlm.nih.gov/19898821/ (added 13/04/2022)

Registry
who.int
Start Date
September 12, 2007
End Date
March 31, 2019
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
South Tees Hospitals NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Male or female subjects, aged 18 years and older.
  • 2\. Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
  • 3\. Subjects who, in the opinion of the Investigator, are able to understand this investigation, co\-operate with the investigational procedures and are willing to return to the hospital for all the required post\-operative follow\-ups.
  • 4\. Subjects who present with idiopathic or posttraumatic osteoarthritis that in the opinion of the clinical investigator requires a primary total knee arthroplasty and who are considered suitable for treatment with P.F.C. Sigma® RP\-F and P.F.C. Sigma® knee systems.
  • 5\. Subjects, who in the opinion of the Clinical Investigator, are considered to be suitable for treatment with both investigational devices, according to the indications specified in the package insert leaflet.

Exclusion Criteria

  • 1\. Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow\-up in this study.
  • 2\. Subjects with a Body Mass Index (BMI) \>35\.
  • 3\. Subjects with a known history of poor compliance to medical treatment.
  • 4\. Women who are pregnant.
  • 5\. Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow\-up care or treatment outcomes.
  • 6\. Subjects involved in Medical\-Legal claims.
  • 7\. Intra\-operative use of augmentation devices.
  • 8\. Intra\-operative decision to resurface the patella based on clinical indication.
  • 9\. Revision of an existing knee implant.

Outcomes

Primary Outcomes

Not specified

Similar Trials